Abstract | BACKGROUND: PATIENTS AND METHODS: Between July 2006 and November 2008, a total of 44 patients with metastatic colorectal cancer received modified FOLFOX6 or FOLFOX4, as first-line chemotherapy at three institutions. They concurrently received either goshajinkigan (group A, n=20) or shakuyakukanzoto (group B, n=24) for neurotoxicity reduction. RESULTS: The median number of treatment cycles and the median cumulative dose of oxaliplatin were 12 cycles (range, 4-19) and 898 mg/m(2) (range, 340-1255) in group A and 10.5 cycles (range, 6-20) and 845 mg/m(2) (range, 510-1480) in group B. Eighteen patients in group A and 24 in group B received oxaliplatin in a cumulative dose exceeding 500 mg/m(2). At a dose of 500 mg/m(2) oxaliplatin, grade 1-2 toxicity occurred in 10 patients of group A and in 7 of group B, but there was no grade 3 or higher toxicity in either group. The response rate of the 38 patients with measurable lesions was 50.0% (9/18) in group A and 65% (13/20) in group B. CONCLUSION: The administration of traditional Japanese medicine may reduce oxalipatin-induced neurotoxicity without negatively affecting tumor response in patients with colorectal cancer who undergo FOLFOX therapy.
|
Authors | Ayumu Hosokawa, Kohei Ogawa, Takayuki Ando, Nobuhiro Suzuki, Akira Ueda, Shinya Kajiura, Yuka Kobayashi, Yuji Tsukioka, Naoki Horikawa, Kazuhisa Yabushita, Junya Fukuoka, Toshiro Sugiyama |
Journal | Anticancer research
(Anticancer Res)
Vol. 32
Issue 7
Pg. 2545-50
(Jul 2012)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 22753712
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Antibodies, Monoclonal, Humanized
- Drug Combinations
- Drugs, Chinese Herbal
- Organoplatinum Compounds
- gosha-jinki-gan
- shakuyaku-kanzoh-toh
- Oxaliplatin
- Bevacizumab
- Leucovorin
- Fluorouracil
|
Topics |
- Aged
- Antibodies, Monoclonal, Humanized
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects, therapeutic use)
- Bevacizumab
- Colorectal Neoplasms
(drug therapy, pathology)
- Drug Combinations
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Fluorouracil
(administration & dosage, adverse effects)
- Glycyrrhiza
- Humans
- Leucovorin
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Neoplasm Metastasis
- Neurotoxicity Syndromes
(etiology, prevention & control)
- Organoplatinum Compounds
(administration & dosage, adverse effects)
- Oxaliplatin
- Paeonia
- Retrospective Studies
|